Rasheda Ali is a Force to be reckoned with in the Fight Against Neurodegenerative Diseases

Log onto IFVNews.com, starting Saturday, March 31st to watch Rasheda Ali's featured interview with IFV News.

IFV News host Marcella Palmer speaks with Rasheda Ali, daughter of legendary boxer Muhammad Ali, former Olympian and three-time World Heavyweight Champion suffering from Parkinson’s Disease. Rasheda discusses her role battling against some of the world’s toughest and most crippling neurocognitive diseases. She has traveled the world speaking to families coping with debilitating diseases such as: Parkinson’s, Alzheimer’s, Multiple Sclerosis, Amyotrophic Lateral Sclerosis (ALS) and Stroke and Spinal Cord injuries. Rasheda's message is encouraging and enlightening, drawing on her personal involvement both as a family member and as a close affiliate to several organizations working to eliminate these diseases. Rasheda is currently affiliated with BrainStorm Cell Therapeutics. BrainStorm is an emerging and innovative biotech company located in Israel, dedicated to providing solutions for incurable neurodegenerative diseases.

About In Full View News (IFV News)
The IFV News Team is focused on bringing its viewers relevant business and financial information in an enjoyable comprehensive web based business news show format. A new webreport airs every Saturday at ifvnews.com. Viewers are encouraged to return daily for articles from trusted sources around the globe monitoring mid-cap, small-cap and micro-cap companies, as well as other medium/small businesses and entrepreneurs (SME). Featured news sources are Forbes, Business Week, BBC News, BusinessWire, PR Newswire, CNET, BusinessGreen and TechCrunch as well as other U.S. and International publications. Viewers are invited to contact IFV News regarding topics of interest. IFV News is a product of M.INK Productions® LLC, http://www.minkproductions.tv

About Rasheda Ali
In answering questions from her own children, Rasheda saw a clear need to provide answers to help other children understand why their loved ones behave a certain way because they have a neurological disorder and was inspired to write the book, I'll Hold Your Hand So You Won't Fall – A Child’s Guide to Parkinson’s Disease. She wanted her book to encourage dialogue and set an example of how clear communication within the family can overcome barriers and improve the quality of life for the whole family. Rasheda’s book has received praise from many influential as well as credible sources. One source, actor and Parkinson Disease advocate, Michael J. Fox, has lent his name to her book and commented, “Rasheda Ali brings home the profound liberation of a child's innate willingness to accept disease without fear." http://www.rashedaali.net

Rasheda is a tireless caregiver advocate on behalf of families fighting Parkinson’s disease and has spoken to many groups- including medical doctors, neurologists, and movement disorder specialists, caregivers and family members of those who suffer from Parkinson’s disease as well as school students, dignitaries, politicians, and social leaders.

The topic of her speech given worldwide is about coping with a Neurological condition and how it affects the family unit. She is a staunch advocate of stem cell research and travels all over the globe speaking about Parkinson’s disease in order to help give encouragement and hope for families struggling with the condition. Her travels have included venues all over the United States, Canada, London, Paris, Madrid, Luxembourg, Poland, Australia, New Zealand, South Africa, and Buenos Aires, Argentina. Her speaking appearances and book signings have raised hundreds of thousands of dollars and more for Parkinson disease organizations all over the globe.

About BrainStorm Cell Therapeutics
BrainStorm is an emerging company developing stem cell therapeutic products based on breakthrough technologies http://www.brainstorm-cell.com. BrainStorm's core technology, NurOwn™, was developed through a collaboration between prominent neurologist, Prof. Eldad Melamed, Head of Neurology of the Rabin Medical Center and member of the Scientific Committee of Michael J. Fox Foundation for Parkinson's Research and expert cell biologist Dr. Daniel Offen, at the Felsenstein Medical Research Center of Tel-Aviv University.

This scientific team is among the first to have successfully demonstrated the physiological release of dopamine from in vitro differentiated bone marrow cells. Moreover, in research conducted by this team, implantation of these cells into the brains of animal models that had been induced to Parkinsonian behavior markedly improved their symptoms. BrainStorm intends to apply the patent-pending technology to the development of innovative autologous cell therapeutic products, NurOwn™, for treatment of neurological diseases.

BrainStorm holds exclusive worldwide rights to commercialize the NurOwn™ technology, through a licensing agreement with Ramot at Tel Aviv University Ltd., the technology transfer company of Tel Aviv University.